In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
An international collaboration was set up to prospectively evaluate the role of allogeneic transplantation for adults with acute lymphoblastic leukemia (ALL) and compare autologous transplantation with standard chemotherapy. Patients received 2 phases of induction and, if in remission, were assigned...
المؤلفون الرئيسيون: | Goldstone, A, Richards, S, Lazarus, H, Tallman, MS, Buck, G, Fielding, A, Burnett, A, Chopra, R, Wiernik, P, Foroni, L, Paietta, E, Litzow, MR, Marks, D, Durrant, J, McMillan, A, Franklin, I, Luger, S, Ciobanu, N, Rowe, J |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2008
|
مواد مشابهة
-
The outcome of 551 1(st) CR transplants in adult ALL from the UKALL XII/ECOG 2993 study
حسب: Goldstone, A, وآخرون
منشور في: (2004) -
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
حسب: Fielding, A, وآخرون
منشور في: (2007) -
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
حسب: Sive, J, وآخرون
منشور في: (2012) -
Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
حسب: Rowe, J, وآخرون
منشور في: (2008) -
Induction therapy for adults with acute lymphoblastic leukemia (ALL): Results of nearly 1,400 patients from the international ALL trial (MRC UKALL XII/ECOG E2993).
حسب: Rowe, J, وآخرون
منشور في: (2003)